The effect of COVID-19 on pain control in patients with a neurostimulator in situ- a retrospective study

Rudrajit Kanjilal,Ananyo Bagchi,Surajit Basu
DOI: https://doi.org/10.1007/s00701-024-06014-0
2024-04-12
Acta Neurochirurgica
Abstract:De-novo chronic neuropathic pain following COVID-19 is widely recognised. However, there are currently no published studies investigating the effect of SARS-CoV-2 infection on patients with pre-existing neuropathic pain who have required spinal cord stimulator (SCS) implantation. Here, the authors aimed to analyse outcomes in their institution's patients who had spinal cord stimulator (SCS) implantation or revision procedures to the system over a 5-year period. Specifically, the short-term and long-term outcomes of patients who contracted COVID-19 during the follow-up period were compared to the control group of patients who did not.
surgery,clinical neurology
What problem does this paper attempt to address?